2023
- 2027
Deciphering metabolic vulnerabilites to improve therapeutic strategies in low survival cancers
Funding sources:
IRSCC/Institut de recherche de la Société canadienne du cancer
Grant programs:
2023
- 2026
Phase I first-in-human trial for ThINKK adoptive immunotherapy in children with high-risk cancers
Funding sources:
IRSC/Instituts de recherche en santé du Canada
Grant programs:
PVXXXXXX-(PJT) Subvention Projet
2022
- 2025
Engineered hematopoietic stem cells (eHSCs) as vehicles for next generation therapies
Lead researcher :
Vincent-Philippe Lavallée
Funding sources:
Stem Cell Network
Grant programs:
2021
- 2025
Dissection génomique et cellulaire des leucémies aiguës et mutations prédisposantes dans la population québécoise
Lead researcher :
Vincent-Philippe Lavallée
Funding sources:
FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Grant programs:
PVXXXXXX-Bourse de chercheur-boursier clinicien : Junior 1
2021
- 2025
Dissection génomique et cellulaire des leucémies aiguës et mutations prédisposantes dans la population québécoise
Lead researcher :
Vincent-Philippe Lavallée
Funding sources:
FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Grant programs:
PVXXXXXX-Établissement de jeunes chercheurs Juniors 1
2022
- 2024
Investigating the mechanisms of relapse and identifying novel prognostic biomarkers in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia
Funding sources:
IRSCC/Institut de recherche de la Société canadienne du cancer
Grant programs:
2022
- 2024
Pediatric Blood Cancer Research Innovation Grant.
Lead researcher :
Vincent-Philippe Lavallée
Funding sources:
LLS Canada/Leukemia and Lymphoma Society of Canada (The)
Grant programs:
2017
- 2024
Interrogating and implementing Omics for precision medicine in Acute Myeloid Leukemia.
Funding sources:
Génome Québec
,
Génome Canada
,
BMS/Bristol-Myers Squibb
,
Génome Canada
Grant programs:
,
PVXXXXXX-Projets de recherche en génomique à grande échelle et Plates-formes scientifiques tech.
,
,
PVXXXXXX-Programme d'aide lié à la COVID-19
2021
- 2023
Optimised transcriptomic and complementary genomic approaches towards clinical grade precision medicine in pediatric oncology
Co-researchers :
Vincent-Philippe Lavallée
Funding sources:
FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Grant programs:
2021
- 2023
Optimised transcriptomic and complementary genomic approaches towards clinical grade precision medicine in pediatric oncology
Co-researchers :
Vincent-Philippe Lavallée
Funding sources:
Génome Québec
Grant programs:
2021
- 2023
Optimised transcriptomic and complementary genomic approaches towards clinical grade precision medicine in pediatric oncology
Co-researchers :
Vincent-Philippe Lavallée
Funding sources:
Fondation Charles Bruneau
Grant programs:
2020
- 2023
Bone marrow stem cell expansion with UM171: a better solution for patients and donors
Co-researchers :
Vincent-Philippe Lavallée
Funding sources:
Stem Cell Network
Grant programs:
2020
- 2023
Hétérogénéité des leucémies et pré-leucémies
Lead researcher :
Vincent-Philippe Lavallée
Funding sources:
COLE Foundation/Fondation Cole
Grant programs:
2019
- 2023
Fonds de démarrage
Lead researcher :
Vincent-Philippe Lavallée
Funding sources:
Fondation de l'Hôpital Ste-Justine
Grant programs:
2020
- 2022
Bone marrow stem cell expansion with UM171: a better solution for patients and donors
Co-researchers :
Vincent-Philippe Lavallée
Funding sources:
Stem Cell Network
Grant programs: